Hikma Pharmaceuticals PLC
HKMPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,168 | $5,351 | $5,650 | $5,161 |
| - Cash | $236 | $188 | $236 | $205 |
| + Debt | $1,558 | $1,306 | $1,276 | $1,191 |
| Enterprise Value | $7,490 | $6,469 | $6,690 | $6,147 |
| Revenue | $1,658 | $1,558 | $1,569 | $1,448 |
| % Growth | 6.4% | -0.7% | 8.4% | – |
| Gross Profit | $725 | $659 | $756 | $692 |
| % Margin | 43.7% | 42.3% | 48.2% | 47.8% |
| EBITDA | $476 | $288 | $499 | $345 |
| % Margin | 28.7% | 18.5% | 31.8% | 23.8% |
| Net Income | $238 | $133 | $226 | $59 |
| % Margin | 14.4% | 8.5% | 14.4% | 4.1% |
| EPS Diluted | 1.07 | 0.6 | 1.01 | 0.27 |
| % Growth | 78.3% | -40.6% | 274.1% | – |
| Operating Cash Flow | $161 | $366 | $198 | $386 |
| Capital Expenditures | -$68 | -$96 | -$69 | -$85 |
| Free Cash Flow | $93 | $270 | $129 | $301 |